- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Misfolding Disease, Protein in United States
Total 147927 results
-
Baxalta now part of ShireCompleted
-
M.D. Anderson Cancer CenterCephalonCompleted
-
Sidney Kimmel Comprehensive Cancer Center at Johns...The Leukemia and Lymphoma SocietyCompletedMultiple MyelomaUnited States
-
Weill Medical College of Cornell UniversityCelgene CorporationTerminatedMultiple MyelomaUnited States
-
M.D. Anderson Cancer CenterTerminated
-
Nationwide Children's HospitalCompleted
-
NYU Langone HealthCephalonTerminated
-
M.D. Anderson Cancer CenterCelgene CorporationTerminated
-
M.D. Anderson Cancer CenterJanssen Services, LLCCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); Parke-DavisCompleted
-
Massachusetts General HospitalTerminatedMultiple Myeloma | Hodgkin Disease | Non Hodgkin's LymphomaUnited States
-
Washington University School of MedicineRecruiting
-
Christopher StrouseUniversity of IowaRecruiting
-
Wake Forest University Health SciencesCelgene; Amgen; Janssen, LPActive, not recruitingMultiple MyelomaUnited States
-
Hackensack Meridian HealthJanssen, LPTerminatedMultiple MyelomaUnited States
-
Hackensack Meridian HealthMillennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
Hackensack Meridian HealthGenentech, Inc.TerminatedA Phase II Study of Bevacizumab and Bortezomib in Patients With Relapsed/Refractory Multiple MyelomaMultiple MyelomaUnited States
-
Hackensack Meridian HealthCompletedMultiple MyelomaUnited States
-
Hackensack Meridian HealthMerck Sharp & Dohme LLCCompletedMultiple MyelomaUnited States
-
RedHill Biopharma LimitedNational Cancer Institute (NCI); Duke University; Apogee Biotechnology CorporationTerminatedMultiple MyelomaUnited States
-
University of ArkansasCelgeneCompletedMultiple MyelomaUnited States
-
University of ArkansasWithdrawn
-
Dartmouth-Hitchcock Medical CenterTerminatedMultiple MyelomaUnited States
-
Washington University School of MedicineMillennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
University of ArkansasCompleted
-
University of ArkansasTerminatedMultiple MyelomaUnited States
-
University of ArkansasTerminatedMultiple MyelomaUnited States
-
Duke UniversityMillennium Pharmaceuticals, Inc.; Duke Cancer InstituteTerminated
-
University of ArkansasWithdrawn
-
University of ArkansasCelgene CorporationCompleted
-
University of ArkansasNovartisTerminated
-
Washington University School of MedicineTerminatedMultiple MyelomaUnited States
-
Washington University School of MedicineTerminatedMultiple MyelomaUnited States
-
University of ArkansasTerminatedMultiple MyelomaUnited States
-
University of ArkansasCompletedMultiple MyelomaUnited States
-
University of ArkansasCompleted
-
University of ArkansasCelgene CorporationCompletedMultiple MyelomaUnited States
-
University of ArkansasCompletedMultiple MyelomaUnited States
-
University of ArkansasCompleted
-
Celgene CorporationCompletedMultiple MyelomaUnited States
-
Attaya SuvannasankhaCompleted
-
National Institute of Allergy and Infectious Diseases...CompletedInfections | Warts | Neutropenia | Myelokathexis | HypogammaglobulinemiaUnited States
-
Icahn School of Medicine at Mount SinaiNational Cancer Institute (NCI)Not yet recruiting
-
Massachusetts General HospitalRecruitingMultiple MyelomaUnited States
-
Mayo ClinicRecruiting
-
Thomas Jefferson UniversityRecruiting
-
Smith GiriRecruitingMultiple MyelomaUnited States
-
M.D. Anderson Cancer CenterRecruiting
-
Loyola UniversityAmgenRecruiting